Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19
The coronavirus disease 2019 (COVID-19) is an unprecedented pandemic that has severely impacted global public health and the economy. Hydroxychloroquine administered orally to COVID-19 patients was ineffective, but its antiviral and anti-inflammatory actions were observed in vitro. The lack of effic...
Main Authors: | Waiting Tai, Michael Yee Tak Chow, Rachel Yoon Kyung Chang, Patricia Tang, Igor Gonda, Robert B. MacArthur, Hak-Kim Chan, Philip Chi Lip Kwok |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/13/8/1260 |
Similar Items
-
Investigation of the Quantity of Exhaled Aerosols Released into the Environment during Nebulisation
by: James A. McGrath, et al.
Published: (2019-02-01) -
Decalogue of nebulisation
by: Adam J. Sybilski
Published: (2019-07-01) -
Vibrating Mesh Nebulisation of Pro-Antimicrobial Peptides for Use in Cystic Fibrosis
by: Éanna Forde, et al.
Published: (2019-05-01) -
Investigation of Fugitive Aerosols Released into the Environment during High-Flow Therapy
by: James A. McGrath, et al.
Published: (2019-06-01) -
Nebuliser Type Influences Both Patient-Derived Bioaerosol Emissions and Ventilation Parameters during Mechanical Ventilation
by: Mary Joyce, et al.
Published: (2021-02-01)